Inaktiver Wert

Andere Sprachen KARA THER

Aktien

A2PM5N

US48576A1007

KRTX

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P Biotechnology Select Industry Index	19.03.
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P TMI Index	19.03.
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P Global BMI Index	19.03.
Rachat de la biotech Karuna par le laboratoire Bristol Myers Squibb finalisé	18.03.
Bristol-Myers Squibb Completes Karuna Therapeutics Acquisition	18.03.
PureTech Health: Bristol Myers Squibb Wraps Up $14 Billion Acquisition of Karuna	18.03.
NVIDIA : Bristol-Myers Squibb, Nvidia, Tesla... les valeurs à suivre aujourd'hui à Wall Street	18.03.
KARA THER : Acquisition/Asset Disposal - Form 8-K	18.03.
Bristol Myers Squibb : finalise le rachat de Karuna	18.03.
Karuna Therapeutics, Inc. and Miramar Merger Sub Inc. Announce Management Changes	18.03.
Bristol Myers : finalise l'acquisition de Karuna Therapeutics	18.03.
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from NASDAQ Composite Index	18.03.
Bristol-Myers Squibb Company completed the acquisition of Karuna Therapeutics, Inc. from Capital International Investors, FMR LLC, The Vanguard Group, Inc., T. Rowe Price Group, Inc. and others.	18.03.
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from NASDAQ Biotechnology Index	15.03.
Karuna Therapeutics : Material Event - Form 8-K	01.03.
Karuna Therapeutics Q4 Loss Widens	22.02.
Karuna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.02.
Karuna Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.02.
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update	22.02.
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX	14.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen KARA THER

Aktien

A2PM5N

US48576A1007

KRTX

Andere Sprachen

Filter